Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Liver
»
Neoplasms
03. May 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3799
Articles 1 - 20 / 75969
Navigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities.
Oncol Res
Hu P, Sun J, Lu J, Ge C, Sun H, Lv C.
PMID: 42065073 [PubMed - indexed for MEDLINE]
Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology.
Oncol Res
Manan A, Ilyas S.
PMID: 42065059 [PubMed - indexed for MEDLINE]
Machine Learning (ML) and Molecular Dynamics-Driven Optimization of VEGFR2 Ligands against Hepatocellular Carcinoma.
Oncol Res
Yasmeen F, Manan A, Kim W, Choi S.
PMID: 42065051 [PubMed - indexed for MEDLINE]
ACSL4 as a context-dependent metabolic switch in hepatocellular carcinoma: implications for ferroptosis and immunotherapy.
Front Immunol
Luo Q, Zhang Z.
PMID: 42064086 [PubMed - indexed for MEDLINE]
Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside.
Front Immunol
Zhang C, Zhang D, Wen X, Liu S.
PMID: 42064051 [PubMed - indexed for MEDLINE]
Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Korean J Radiol
Jeong B, Park HJ, Choi WM, Choi SH, Kim KW, Kim SY, Lee SS.
PMID: 42062227 [PubMed - indexed for MEDLINE]
International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.
Lancet Oncol
Laimer G, Johnston EW, Overduin CG, Paolucci I, Ahmed M, Arellano RS, Beermann M, Beyer LP, Breen DJ, Burgmans MC, Calandri M, Chern MC, Crocetti L, van Dam RM, Denys A, Edwin B, Filippiadis D, Fong Y, Fotiadis N, Freedman J, Fretland ÅA, Gimenez M, Garcia RG, Grasso RF, Helmberger TK, Hendriks P, Iezzi R, Jenniskens SF, Kupferthaler A, Lachenmayer A, Lee FT Jr, Lee JM, van der Lei S, van der Leij C, Liang P, Lin CC, Luerken L, Maglione M, Mahnken A, McWilliams JP, Menezes M, Narayanan G, Orsi F, Pereira PL, Pua U, Puijk RS, Rhim H, Rilling WS, Ruiter SJS, Ryan AG, Schullian P, Shyn PB, Siriwardena AK, Smits MLJ, Sofocleous CT, Solbiati L, Sotirchos V, Stättner S, van Strijen M, Syversveen T, Tinguely P, Tselikas L, Vauthey JN, Vogl TJ, Wah TM, White SB, Wiggermann P, Wood BJ, van der Meulen J, Goldberg SN, Meijerink MR, Odisio BC, Bale R.
PMID: 42061383 [PubMed - indexed for MEDLINE]
International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.
Lancet Oncol
Paolucci I, Overduin CG, Johnston EW, Laimer G, Ahmed M, Arellano RS, Beerman M, Beyer LP, Breen DJ, Burgmans MC, Calandri M, Chern MC, Crocetti L, van Dam RM, Denys A, Edwin B, Filippiadis D, Fong Y, Fotiadis N, Freedman J, Fretland ÅA, Gimenez M, Garcia RG, Grasso RF, Helmberger TK, Hendriks P, Iezzi R, Jenniskens SF, Kupferthaler A, Lachenmayer A, Lee FT Jr, Lee JM, van der Lei S, van der Leij C, Liang P, Lin CC, Luerken L, Maglione M, Mahnken A, McWilliams JP, Menezes M, Narayanan G, Orsi F, Pereira PL, Pua U, Puijk RS, Rhim H, Rilling WS, Ruiter SJS, Ryan AG, Schullian P, Shyn PB, Siriwardena AK, Smits MLJ, Sofocleous CT, Solbiati L, Sotirchos V, Stättner S, van Strijen M, Syversveen T, Tinguely P, Tselikas L, Vauthey JN, Vogl TJ, Wah TM, White SB, Wiggermann P, Wood BJ, van der Meulen J, Goldberg SN, Meijerink MR, Bale R, Odisio BC.
PMID: 42061382 [PubMed - indexed for MEDLINE]
Hepatosplenic T-cell Lymphoma Masquerading as Idiopathic Cytopenia.
Malays J Pathol
Raghvan HP, Wee SY, Liam CCK, Mohd Shakri N, Ho CSL, Jamian E, Subbiah I, Khalid N.
PMID: 42059175 [PubMed - indexed for MEDLINE]
Macrophage-related Genomic Signatures Predict HCC Prognosis and Therapy Response.
Cancer Genomics Proteomics
Zhong W, Duan L, Zhang F, Zou C, Qiu J, Hu S, Yu M, Yin ZI.
PMID: 42055628 [PubMed - indexed for MEDLINE]
Multifunctional double hairpin DNA polydopamine nano-system for "switch-on" detection and intervention of high-grade dysplastic nodules.
Mikrochim Acta
Zhou J, Feng J, Dong X, Zhang T, Wei Y, Wang Y, Shi C.
PMID: 42053823 [PubMed - indexed for MEDLINE]
Beyond silencing: integrative multi-omics and spatial profiling unravel the systems-level role of piRNAs in HBV-driven Hepatocarcinogenesis.
Mol Biol Rep
Zainb A, Altalbawy FMA, Younis SMD, Ali Al-Bazi SM, Eiada AA, Zain Al-Abdeen SH, Norberdiyeva M, Smerat A.
PMID: 42053692 [PubMed - indexed for MEDLINE]
Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies.
Front Immunol
Wang Z, Wu J, Li Q, Wen X.
PMID: 42051530 [PubMed - indexed for MEDLINE]
Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review.
Front Immunol
Jin Y, Fu L, Zhao Y, Tong Z, Tan Y.
PMID: 42051505 [PubMed - indexed for MEDLINE]
Is PD-1/PD-L1 inhibitor plus bevacizumab superior to sorafenib as first-line treatment for advanced hepatocellular carcinoma? A pooled analysis of four phase 3 RCTs.
BMC Gastroenterol
Zhong Q, Li H, Hu W, Li Z, Hu Z.
PMID: 42050438 [PubMed - indexed for MEDLINE]
New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report.
In Vivo
Tsai YC, Lin CH, Hung CH, Ou JJ, Lee YT.
PMID: 42049452 [PubMed - indexed for MEDLINE]
Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation.
Anticancer Res
Tanaka K, Kuwano A, Yada M, Suzuki H, Motomura K.
PMID: 42049332 [PubMed - indexed for MEDLINE]
AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma.
Cancer Immunol Immunother
Ren Z, Huang Y, Guo Y, Hou MM, Wang W, Kuang M, Hao C, Wang W, Zhang Y, Song T, Dai C, Kuo HT, Bao Z, Zuo Y, Wang L, Zhu F, Fan J.
PMID: 42047833 [PubMed - indexed for MEDLINE]
CEUS-Based Microvascular Invasion Predictor in HCC: Improving Prognostic Stratification Following Thermal Ablation.
Liver Int
Chen K, Zhang S, Huang T, Xu Y, Zhang Q, Zhu Y, Wan P, Kong W, Wang W.
PMID: 42047408 [PubMed - indexed for MEDLINE]
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Chinese Retrospective Multicenter Study Based on Global Meta-Analysis.
Cancer Med
Xu J, Zhang YL, Yang M, Deng Z, Li L, Wang T, Song J, Xu H, Wu J, Wu ZQ, Xu HG.
PMID: 42047297 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 75969
Page 1 of 3799
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy